Nanocarriers for Improved Delivery of Angiotensin-(1-7)

[1]  M. Chapleau,et al.  Chronic oral administration of Ang-(1-7) improves skeletal muscle, autonomic and locomotor phenotypes in muscular dystrophy. , 2014, Clinical science.

[2]  R. Santos.  Angiotensin-(1-7). , 2014, Hypertension.

[3]  N. Stergiopulos,et al.  Treatment with Angiotensin-(1–7) reduces inflammation in carotid atherosclerotic plaques , 2014, Thrombosis and Haemostasis.

[4]  K. Casali,et al.  An orally active angiotensin-(1–7) inclusion compound and exercise training produce similar cardiovascular effects in spontaneously hypertensive rats , 2014, Peptides.

[5]  N. Stergiopulos,et al.  Pathophysiological role of the renin–angiotensin system on erectile dysfunction , 2013, European journal of clinical investigation.

[6]  J. D. Feltenberger,et al.  Oral Formulation of Angiotensin-(1–7) Improves Lipid Metabolism and Prevents High-Fat Diet–Induced Hepatic Steatosis and Inflammation in Mice , 2013, Hypertension.

[7]  E. Reed,et al.  Pharmacodynamic stimulation of thrombogenesis by angiotensin (1–7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy , 2013, Cancer Chemotherapy and Pharmacology.

[8]  V. Torchilin,et al.  Liposomes for cardiovascular targeting. , 2012, Therapeutic delivery.

[9]  N. Alenina,et al.  An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect , 2011, Clinics.

[10]  A. Ferreira,et al.  An Oral Formulation of Angiotensin-(1-7) Produces Cardioprotective Effects in Infarcted and Isoproterenol-Treated Rats , 2011, Hypertension.

[11]  F. Frézard,et al.  New insights into the mode of action of ultradeformable vesicles using calcein as hydrophilic fluorescent marker. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[12]  G. E. El Maghraby,et al.  Liposomes and skin: from drug delivery to model membranes. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[13]  H. A. Duarte,et al.  Study of angiotensin-(1–7) vasoactive peptide and its β-cyclodextrin inclusion complexes: Complete sequence-specific NMR assignments and structural studies , 2007, Peptides.

[14]  R. Mehrian-Shai,et al.  Expression of intracellular filament, collagen, and collagenase genes in diabetic and normal skin after injury , 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[15]  Frédéric Frézard,et al.  Lipossomas: propriedades físico-químicas e farmacológicas, aplicações na quimioterapia à base de antimônio , 2005 .

[16]  G. Cevc.  Lipid vesicles and other colloids as drug carriers on the skin. , 2004, Advanced drug delivery reviews.

[17]  F. Frézard,et al.  Site-specific microinjection of liposomes into the brain for local infusion of a short-lived peptide. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[18]  F. Frézard,et al.  Long-Lasting Cardiovascular Effects of Liposome-Entrapped Angiotensin-(1-7) at the Rostral Ventrolateral Medulla , 2001, Hypertension.

[19]  F. Hirayama,et al.  Cyclodextrin-based controlled drug release system. , 1999, Advanced drug delivery reviews.

[20]  F. Frézard,et al.  Liposomes: from biophysics to the design of peptide vaccines. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[21]  D. Ganten,et al.  Converting enzyme determines plasma clearance of angiotensin-(1-7). , 1998, Hypertension.

[22]  M. Campagnole-Santos,et al.  Cardiovascular effects produced by microinjection of angiotensins and angiotensin antagonists into the ventrolateral medulla of freely moving rats , 1997, Brain Research.

[23]  R. Hoffman,et al.  Topical liposome delivery of molecules to hair follicles in mice. , 1997, Journal of dermatological science.

[24]  S. Simões,et al.  Sterically Stabilized pH-sensitive Liposomes , 1997, The Journal of Biological Chemistry.

[25]  N. Weiner,et al.  Targeted delivery to the pilosebaceous unit via liposomes , 1996 .

[26]  G. Cevc,et al.  Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. , 1992, Biochimica et biophysica acta.

[27]  M. Mezei,et al.  Liposomes--a selective drug delivery system for the topical route of administration. Lotion dosage form. , 1980, Life sciences.

[28]  S. Santos,et al.  Oral administration of angiotensin-(1–7) ameliorates type 2 diabetes in rats , 2013, Journal of Molecular Medicine.

[29]  S. Louie,et al.  Toxicological and toxicokinetic analysis of angiotensin (1-7) in two species. , 2012, Journal of pharmaceutical sciences.

[30]  D. Momekova,et al.  Long-circulating, pH-sensitive liposomes. , 2010, Methods in molecular biology.